Markers of Kidney Injury, Inflammation, and Fibrosis Associated With Ertugliflozin in Patients With CKD and Diabetes.

Kidney Int Rep · 2021 · PMC8343791 · PMID 34386658

Europe PMC DOI

hedged sentence

0.0600

closest p · 1.2× alpha

0.0600

boldest claim

The sentences

did not reach statistical significanceP = 0.06so close (0.05 < p ≤ 0.1)

A similar trend was noted comparing baseline KIM-1 with the change in eGFR from 26 to 52 weeks, although this did not reach statistical significance (Pearson’s r = −0.14, P = 0.06).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.